Nature of the Business - Additional Information (Details) $ / shares in Units, $ in Thousands				1 Months Ended	3 Months Ended	6 Months Ended
	Feb. 24, 2021 USD ($) shares	Feb. 17, 2021 $ / shares shares	Feb. 05, 2021	Mar. 31, 2022 USD ($) shares	Mar. 31, 2021 USD ($) shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2021 USD ($) shares	Dec. 31, 2021 $ / shares shares	Dec. 31, 2020 shares
Nature Of Business Disclosure [Line Items]
Common stock par value | $ / shares						$ 0.001		$ 0.001
Issuance of common stock upon closing of IPO					$ 124,779
Aggregate proceeds from initial public offering	$ 125,000
Proceeds from issuance of common stock							$ 128,240
Cash, cash equivalents and available-for-sale securities						$ 125,600
Initial Public Offering
Nature Of Business Disclosure [Line Items]
Number of shares issued and sold | shares		7,062,000
Stock issued, price per share | $ / shares		$ 18.00
Underwriters
Nature Of Business Disclosure [Line Items]
Number of shares issued and sold | shares	600,000
At-the-Market | Maximum
Nature Of Business Disclosure [Line Items]
Issuance of common stock upon closing of IPO						$ 20,000
Common Stock
Nature Of Business Disclosure [Line Items]
Reverse stock-split, description						On February 5, 2021, the Company’s board of directors approved a 1-for-5.3 reverse stock split of the Company’s common stock.
Reverse stock-split ratio			0.1886
Number of shares issued and sold | shares					7,662,000
Shares outstanding | shares				24,956,556	24,859,038	24,959,848	24,868,817	24,951,983	521,052
Issuance of common stock upon closing of IPO					$ 7
Common Stock | Maximum
Nature Of Business Disclosure [Line Items]
Issuance of common stock upon closing of IPO				$ 200,000
Common Stock | At-the-Market
Nature Of Business Disclosure [Line Items]
Shares outstanding | shares						0
Percentage of compensation on gross proceeds common stock sold						3.00%